References

Current and emerging therapies for targeting the ERK1/2 & PI3K Pathways in Cancer

10.3390/ijms26178696 · 2025 · External reference

ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)

2003 · External reference

Autophagy and cancer dormancy

10.3389/fonc.2021.627023 · 2021 · External reference

Tumor angiogenesis: current challenges and therapeutic opportunities

2021 · External reference

Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice

10.1126/science.aao4227 · 2018 · External reference

Targeting tumor dormancy and recurrence: molecular mechanisms and peptide therapeutic delivery

10.1002/mog2.70050 · 2026 · External reference

Multifunctional peptide- and natural polymer-based smart biomaterials: Synthetic approaches and cancer treatment applications

10.1016/j.ccr.2025.216980 · 2025 · External reference

Recent advances in natural biomaterial-based hydrogels for controlled drug release and cancer immunotherapy applications

10.26599/nr.2025.94908152 · 2025 · External reference

Atomic force microscopy of biological samples

10.1002/wnan.104 · 2010 · External reference

Dormancy in colorectal cancer: The functional core of resistance, metastasis, and relapse

10.1016/j.critrevonc.2025.105081 · 2026 · External reference

Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins

10.3390/cells13131087 · 2024 · External reference

CAF-induced physical constraints controlling T cell state and localization in solid tumours

10.1038/s41568-024-00740-4 · 2024 · External reference

Combinatorial regulation by ERK1/2 and CK1δ protein kinases leads to HIF-1α association with microtubules and facilitates its symmetrical distribution during mitosis

10.1007/s00018-024-05120-7 · 2024 · External reference

Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma

10.1038/s41419-020-2586-x · 2020 · External reference

AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer

10.1158/1541-7786.mcr-18-0718 · 2019 · External reference

Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche

10.1016/j.cell.2022.03.033 · 2022 · External reference

10.1007/s00259-024-06704-y

10.1007/s00259-024-06704-y · External reference

Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT

2020 · External reference

β1-integrin: a potential therapeutic target in the battle against cancer recurrence

10.1158/1078-0432.ccr-11-0642 · 2011 · External reference

Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton

10.1158/0008-5472.can-07-6849 · 2008 · External reference

Tumor cell-organized fibronectin maintenance of a dormant breast cancer population

10.1126/sciadv.aaz4157 · 2020 · External reference

Decoding the adaptive survival mechanisms of breast cancer dormancy

10.1038/s41388-025-03529-3 · 2025 · External reference

Cells on lockdown: long-term consequences of CDK4/6 inhibition

10.15252/embj.2022110764 · 2022 · External reference

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor

10.1016/j.cell.2017.11.037 · 2018 · External reference

Clusterin is regulated by IGF1-PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity

10.1007/s00204-020-02709-2 · 2020 · External reference

Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis

10.1016/j.semcancer.2021.04.021 · 2022 · External reference

Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study

10.1016/s2352-3026(24)00033-4 · 2024 · External reference

Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer

10.1016/j.cyto.2023.156376 · 2023 · External reference

Epigenetic modifications of autophagy in cancer and cancer therapeutics

10.1016/j.semcancer.2019.05.020 · 2020 · External reference

DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy

10.1158/1535-7163.mct-21-0331 · 2022 · External reference

Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma

10.3390/cells10030621 · 2021 · External reference

Cellular and molecular mechanisms of asymmetric stem cell division in tissue homeostasis

10.1111/gtc.13172 · 2024 · External reference

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

10.1186/s13058-018-1049-0 · 2018 · External reference

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling

10.1038/ncb2861 · 2013 · External reference

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge

10.1038/s41523-021-00269-x · 2021 · External reference

Prostate cancer dormancy and recurrence

10.1016/j.canlet.2021.09.037 · 2022 · External reference

Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression

2018 · External reference

Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry

10.1038/s41416-019-0501-y · 2019 · External reference

Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia

10.1002/jcb.25972 · 2017 · External reference

Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy

10.1038/s41556-018-0267-0 · 2019 · External reference

Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation

10.1016/j.canlet.2024.216792 · 2024 · External reference

Therapeutic targeting of minimal residual disease to prevent late recurrence in hormone-receptor positive breast cancer: challenges and new approaches

2021 · External reference

Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies

10.1016/j.bbcan.2025.189360 · 2025 · External reference

The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity

10.3389/fonc.2020.578418 · 2020 · External reference

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response

10.1038/s41586-018-0392-8 · 2018 · External reference

Cancer stem cell quiescence and plasticity as major challenges in cancer therapy

10.1155/2016/1740936 · 2016 · External reference

Akt regulated phosphorylation of GSK-3β/Cyclin D1, p21 and p27 contributes to cell proliferation through cell cycle progression from G1 to S/G2M phase in low-dose arsenite exposed HaCat cells

10.3389/fphar.2019.01176 · 2019 · External reference

Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth

10.1080/15548627.2021.1973338 · 2022 · External reference

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

10.1038/s41392-023-01332-8 · 2023 · External reference

TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization

10.1038/s41375-018-0222-x · 2019 · External reference

Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation

10.1038/s41419-024-07089-4 · 2024 · External reference

Fibroblasts in cancer: unity in heterogeneity

10.1016/j.cell.2023.03.016 · 2023 · External reference

Respiratory viral infections awaken metastatic breast cancer cells in lungs

10.1038/s41586-025-09332-0 · 2025 · External reference

Author correction: natural killer cells and other innate lymphoid cells in cancer

10.1038/s41577-018-0077-4 · 2018 · External reference

Targeting AXL inhibits the growth and metastasis of prostate cancer in bone

10.1158/1078-0432.ccr-24-3028 · 2025 · External reference

Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma

10.3892/or.2022.8359 · 2022 · External reference

Cancer stem cells: advances in knowledge and implications for cancer therapy

10.1038/s41392-024-01851-y · 2024 · External reference

HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer

10.1038/s41388-021-01931-1 · 2021 · External reference

Role of myeloid-derived suppressor cells in tumor recurrence

10.1007/s10555-023-10079-1 · 2023 · External reference

Tracking dormant disseminated tumour cells

10.1038/s41568-022-00480-3 · 2022 · External reference

Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy

10.1038/s41586-021-03614-z · 2021 · External reference

Analysis of dormancy-associated transcriptional networks reveals a shared quiescence signature in lung and colorectal cancer

10.3390/ijms23179869 · 2022 · External reference

Outlook for new CAR-based therapies with a focus on CAR NK cells: what lies beyond CAR-engineered T cells in the race against cancer

10.1158/2159-8290.cd-20-0556 · 2021 · External reference

Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis

10.1016/j.cell.2024.09.016 · 2024 · External reference

Targeting dormant tumor cells to prevent cancer recurrence

10.1111/febs.15626 · 2021 · External reference

Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer

10.1016/j.semcancer.2019.08.020 · 2020 · External reference

Circulating and disseminated tumor cells: harbingers or initiators of metastasis?

10.1002/1878-0261.12022 · 2017 · External reference

Roles for the FCRL6 immunoreceptor in tumor immunology

10.3389/fimmu.2020.575175 · 2020 · External reference

Stem cell plasticity and dormancy in the development of cancer therapy resistance

10.3389/fonc.2019.00626 · 2019 · External reference

Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT

10.3390/ijms19072011 · 2018 · External reference

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer

10.1172/jci137552 · 2020 · External reference

Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity

10.1038/s41580-022-00568-6 · 2023 · External reference

AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells

10.1038/s41378-020-0131-9 · 2020 · External reference

Insights into the role of senescence in tumor dormancy: mechanisms and applications

10.1007/s10555-023-10082-6 · 2023 · External reference

Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial

10.1038/s41591-025-03877-3 · 2025 · External reference

Drug-tolerant persister cells in cancer therapy resistance

10.1158/0008-5472.can-21-3844 · 2022 · External reference

Remodeling the ECM: implications for metastasis and tumor dormancy

10.3390/cancers13194916 · 2021 · External reference

A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy

10.1038/s43018-021-00291-9 · 2022 · External reference

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

10.1016/j.bbrc.2024.150339 · 2024 · External reference

Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy

10.1186/s13058-024-01878-7 · 2024 · External reference

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

10.1016/j.ccr.2009.01.021 · 2009 · External reference

HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer

10.1016/j.jbo.2021.100407 · 2021 · External reference

Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies

10.1016/j.canlet.2024.216894 · 2024 · External reference

Dormancy in cancer

10.1111/cas.13917 · 2019 · External reference

The metastatic cascade as the basis for liquid biopsy development

10.3389/fonc.2020.01055 · 2020 · External reference

Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation

10.1038/s44318-024-00319-7 · 2025 · External reference

Stromal changes in the aged lung induce an emergence from melanoma dormancy

10.1038/s41586-022-04774-2 · 2022 · External reference

Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies

10.7150/thno.113665 · 2025 · External reference

Tuning hydrogel adhesivity and degradability to model the influence of premetastatic niche matrix properties on breast cancer dormancy and reactivation

2022 · External reference

p38 mitogen-activated protein kinase inhibition of mesenchymal transdifferentiated tumor cells in head and neck squamous cell carcinoma

10.3390/biomedicines11123301 · 2023 · External reference

Knocking-Down CD147/EMMPRIN Expression in CT26 colon carcinoma forces the cells into cellular and angiogenic dormancy that can be reversed by interactions with macrophages

10.3390/biomedicines11030768 · 2023 · External reference

Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments

10.1038/ncb3465 · 2017 · External reference

Oncogenic signals prime cancer cells for toxic cell overgrowth during a G1 cell cycle arrest

10.1016/j.molcel.2023.10.020 · 2023 · External reference

A pre-existing population of ZEB2(+) quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer

10.1186/s13046-019-1505-4 · 2020 · External reference

Interferon-γ induces immunosuppression in salivary adenoid cystic carcinoma by regulating programmed death ligand 1 secretion

10.1038/s41368-022-00197-x · 2022 · External reference

Taxane chemotherapy induces stromal injury that leads to breast cancer dormancy escape

10.1371/journal.pbio.3002275 · 2023 · External reference

NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway

10.1186/s12885-019-5925-5 · 2019 · External reference

Metastasis organotropism: redefining the congenial soil

10.1016/j.devcel.2019.04.012 · 2019 · External reference

A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival

10.1016/j.leukres.2021.106555 · 2021 · External reference

Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance

10.1007/s10555-021-10003-5 · 2022 · External reference

Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype

10.1002/ijc.29375 · 2016 · External reference

The perivascular niche regulates breast tumour dormancy

10.1038/ncb2767 · 2013 · External reference

The glycocalyx and immune evasion in cancer

10.1111/febs.16236 · 2023 · External reference

TGF-β signaling: critical nexus of fibrogenesis and cancer

10.1186/s12967-024-05411-4 · 2024 · External reference

Dormant tumour cells, their niches and the influence of immunity

10.1038/s41556-018-0214-0 · 2018 · External reference

Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies

10.1016/j.ccell.2023.12.011 · 2024 · External reference

Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury

10.1038/s41392-023-01444-1 · 2023 · External reference

Biomarkers for the detection of circulating tumor cells

10.1016/j.yexcr.2025.114555 · 2025 · External reference

Shaping oncogenic microenvironments: contribution of fibronectin

10.3389/fcell.2024.1363004 · 2024 · External reference

DIRAS3 inhibits ovarian cancer cell growth by blocking the fibronectin-mediated integrin β1/FAK/AKT signaling pathway

10.3390/cells14161250 · 2025 · External reference

Notch signaling, hypoxia, and cancer

2023 · External reference

The endosteal niche in breast cancer bone metastasis

10.3389/fonc.2020.00335 · 2020 · External reference

Perioperative escape from dormancy of spontaneous micro-metastases: A role for malignant secretion of IL-6, IL-8, and VEGF, through adrenergic and prostaglandin signaling

10.1016/j.bbi.2023.01.005 · 2023 · External reference

Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment

10.3389/fcell.2024.1310442 · 2024 · External reference

Biotechnological advances in 3D modeling of cancer initiation. Examples from pancreatic cancer research and beyond

10.1088/1758-5090/adb51c · 2025 · External reference

Cell cycle arrest determines adult neural stem cell ontogeny by an embryonic Notch-nonoscillatory Hey1 module

10.1038/s41467-021-26605-0 · 2021 · External reference

Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps

10.1016/j.ccell.2025.06.007 · 2025 · External reference

Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies

10.1038/s41392-024-01891-4 · 2024 · External reference

Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors

10.1007/s10555-022-10075-x · 2023 · External reference

Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities

10.1016/j.semcancer.2019.09.002 · 2020 · External reference

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

10.1038/nm0295-149 · 1995 · External reference

Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine

10.1038/s12276-023-00951-z · 2023 · External reference

Early dissemination seeds metastasis in breast cancer

10.1038/nature20785 · 2016 · External reference

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

10.1038/s41586-023-05880-5 · 2023 · External reference

Hif-1α and Hif-2α differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells

10.1016/j.canlet.2014.03.035 · 2014 · External reference

Quantitative evidence for early metastatic seeding in colorectal cancer

10.1038/s41588-019-0423-x · 2019 · External reference

Single-cell analysis unveils the role of the tumor immune microenvironment and notch signaling in dormant minimal residual disease

10.1158/0008-5472.can-21-1230 · 2022 · External reference

Antiangiogenic therapy in oncology: current status and future directions

10.1016/s0140-6736(15)01088-0 · 2016 · External reference

Active autophagy in cancer-associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response

10.1002/jcp.30419 · 2021 · External reference

Thrombospondin 1 triggers osteosarcoma cell metastasis and tumor angiogenesis

10.3727/096504018x15208993118389 · 2019 · External reference

PRRX1 regulates cellular phenotype plasticity and dormancy of head and neck squamous cell carcinoma through miR-642b-3p

10.1016/j.neo.2018.12.001 · 2019 · External reference

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

10.1016/s1470-2045(19)30164-0 · 2019 · External reference

Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis

10.1002/ctm2.1567 · 2024 · External reference

HIF-1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell-like diffuse large B-cell lymphoma cells

10.1002/mc.23515 · 2023 · External reference

Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement

10.1172/jci.insight.120360 · 2018 · External reference

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow

10.1038/ncb3408 · 2016 · External reference

Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow

10.18632/oncotarget.8365 · 2016 · External reference

Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells

2018 · External reference

An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy

10.1084/jem.20210836 · 2022 · External reference

Cancer metastasis: molecular mechanisms and clinical perspectives

10.1016/j.pharmthera.2023.108522 · 2023 · External reference

A niche-dependent myeloid transcriptome signature defines dormant myeloma cells

10.1182/blood.2018880930 · 2019 · External reference

Involvement of extracellular vesicles in vascular-related functions in cancer progression and metastasis

10.3390/ijms20102584 · 2019 · External reference

Salidroside, 8(E)-nuezhenide, and ligustroside from ligustrum japonicum fructus inhibit expressions of MMP-2 and -9 in HT 1080 fibrosarcoma

10.3390/ijms23052660 · 2022 · External reference

Cancer, metastasis, and the epigenome

10.1186/s12943-024-02069-w · 2024 · External reference

Tumor dormancy and disease recurrence

10.1007/s10555-023-10096-0 · 2023 · External reference

The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy

10.1126/scitranslmed.aan3464 · 2018 · External reference

Targeting intercellular communication in the bone microenvironment to prevent disseminated tumor cell escape from dormancy and bone metastatic tumor growth

10.3390/ijms22062911 · 2021 · External reference

Extracellular vesicles in tumor immunity: mechanisms and novel insights

10.1186/s12943-025-02233-w · 2025 · External reference

Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype

10.3389/fcell.2021.645593 · 2021 · External reference

Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression

10.1038/s41467-019-11640-9 · 2019 · External reference

Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells

10.7150/thno.63763 · 2021 · External reference

Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (pre)analytical work flows

10.1373/clinchem.2019.306837 · 2020 · External reference

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

10.1038/s41388-018-0624-2 · 2019 · External reference

A live tracker of dormant disseminated tumor cells

10.1007/978-1-0716-3882-8_11 · 2024 · External reference

Potential of uPAR, αvβ6 integrin, and tissue factor as targets for molecular imaging of oral squamous cell carcinoma: evaluation of nine targets in primary tumors and metastases by immunohistochemistry

10.3390/ijms24043853 · 2023 · External reference

The interplay between circulating tumor cells and the immune system: from immune escape to cancer immunotherapy

2018 · External reference

Drug-tolerant persister cell in cancer: reversibility, microenvironmental interplay, and therapeutic strategies

2025 · External reference

Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway

2019 · External reference

CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway

10.1371/journal.pone.0334639 · 2025 · External reference

Tumor microenvironment diversity and plasticity in cancer multidrug resistance

10.1016/j.bbcan.2023.188997 · 2023 · External reference

A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy

10.1038/s41565-022-01098-0 · 2022 · External reference

Decoding metastatic microenvironments through single-cell omics reveals new insights into niche dynamics and tumor evolution

10.1371/journal.pbio.3003299 · 2025 · External reference

Cross-talk between cancer-associated fibroblasts and dormant cancer cells: current status and promising therapeutic potential

10.1186/s12935-025-04120-2 · 2025 · External reference

PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers

10.1038/s41419-020-02998-6 · 2020 · External reference

Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces

10.1016/j.canlet.2024.216899 · 2024 · External reference

Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma

10.1038/s41413-022-00237-6 · 2023 · External reference

STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells

10.1172/jci96329 · 2018 · External reference

Biomarkers and targeted therapy for cancer stem cells

10.1016/j.tips.2023.11.006 · 2024 · External reference

Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63

10.1038/s41467-021-25552-0 · 2021 · External reference

Natural killer cells lull tumours into dormancy

10.1038/d41586-021-01381-5 · 2021 · External reference

Exosomal PD-L1 in cancer and other fields: recent advances and perspectives

2024 · External reference

Tumor angiogenesis: causes, consequences, challenges and opportunities

10.1007/s00018-019-03351-7 · 2020 · External reference

Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment

2025 · External reference

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

10.1038/s41392-022-01080-1 · 2022 · External reference

Unraveling the mystery of breast cancer dormancy: insights into genetic, receptor, and cellular interactions driving late recurrence

2025 · External reference

Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth

10.1084/jem.20191820 · 2020 · External reference

A systematic analysis of negative growth control implicates the DREAM complex in cancer cell dormancy

10.1158/1541-7786.mcr-16-0323-t · 2017 · External reference

Differential cell-cycle control by oscillatory versus sustained Hes1 expression via p21

10.1016/j.celrep.2023.112520 · 2023 · External reference

Hypoxia alters the response to anti-EGFR therapy by regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner

10.1158/0008-5472.can-20-1232 · 2020 · External reference

Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse

10.1016/j.semcancer.2021.03.023 · 2022 · External reference

The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties

10.1016/j.canlet.2014.10.035 · 2015 · External reference

The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts

10.1002/cncr.31935 · 2019 · External reference

Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity

10.1016/j.immuni.2022.03.013 · 2022 · External reference

Distinct contribution of stem and progenitor cells to epidermal maintenance

10.1038/nature11393 · 2012 · External reference

Metabolic adaptations in cancer stem cells: A key to therapy resistance

10.1016/j.bbadis.2024.167164 · 2024 · External reference

Hypoxia-drives reversible cell cycle arrest in lung cancer cells via modulation of cellular redox and gene expression

10.1007/s12032-025-03058-9 · 2025 · External reference

Persister cell plasticity in tumour drug resistance

10.1016/j.semcdb.2023.11.003 · 2024 · External reference

Senescence as a therapeutic target in cancer and age-related diseases

10.1038/s41573-024-01074-4 · 2025 · External reference

Mechanism of drug tolerant persister cancer cells: the landscape and clinical implication for therapy

10.1016/j.jtho.2021.07.017 · 2021 · External reference

FF-10502, an antimetabolite with novel activity on dormant cells, is superior to gemcitabine for targeting pancreatic cancer cells

10.1124/jpet.118.248740 · 2018 · External reference

New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape

10.1016/j.coi.2014.01.004 · 2014 · External reference

Collective cancer cell invasion in contact with fibroblasts through integrin-α5β1/fibronectin interaction in collagen matrix

10.1111/cas.14664 · 2020 · External reference

Notch signaling enhances stemness by regulating metabolic pathways through modifying p53, NF-κB, and HIF-1α

10.1089/scd.2017.0260 · 2018 · External reference

CXCL12/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis

10.1016/j.lfs.2020.117534 · 2020 · External reference

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

10.1016/j.imlet.2019.11.007 · 2020 · External reference

Autophagy in cancer metastasis

10.1038/onc.2016.333 · 2017 · External reference

Metastatic cell dormancy and re-activation: an overview on series of molecular events critical for cancer relapse

10.2174/1871520616666160901145857 · 2017 · External reference

C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions

10.7150/jca.78993 · 2023 · External reference

Organoid-immune co-cultures: a next-generation approach to disease modeling

10.1007/s11033-026-11450-5 · 2026 · External reference

Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data

10.1016/j.canlet.2018.06.002 · 2018 · External reference

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

10.1093/jnci/djj068 · 2006 · External reference

Mechanisms of metastatic tumor dormancy and implications for cancer therapy

10.3390/ijms20246158 · 2019 · External reference

Bone marrow NG2(+)/Nestin(+) mesenchymal stem cells drive DTC dormancy via TGFβ2

10.1038/s43018-021-00179-8 · 2021 · External reference

Treating cancer with selective CDK4/6 inhibitors

10.1038/nrclinonc.2016.26 · 2016 · External reference

Cell-matrix interface regulates dormancy in human colon cancer stem cells

10.1038/s41586-022-05043-y · 2022 · External reference

gp130 cytokines activate novel signaling pathways and alter bone dissemination in ER+ breast cancer cells

10.1002/jbmr.4430 · 2022 · External reference

Cycling cancer persister cells arise from lineages with distinct programs

10.1038/s41586-021-03796-6 · 2021 · External reference

Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models

10.1186/s12885-016-2850-8 · 2016 · External reference

Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone

10.15252/embr.202050162 · 2020 · External reference

Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators

10.1073/pnas.1101139108 · 2012 · External reference

Liquid biopsy and minimal residual disease - latest advances and implications for cure

10.1038/s41571-019-0187-3 · 2019 · External reference

Immunoengineering can overcome the glycocalyx armour of cancer cells

10.1038/s41563-024-01808-0 · 2024 · External reference

The force awakens: metastatic dormant cancer cells

10.1038/s12276-020-0423-z · 2020 · External reference

The role of the ECM in lung cancer dormancy and outgrowth

10.3389/fonc.2020.01766 · 2020 · External reference

The role of RNA processing and regulation in metastatic dormancy

10.1016/j.semcancer.2021.03.020 · 2022 · External reference

Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges

10.1016/j.phrs.2022.106553 · 2023 · External reference

Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2

10.1186/s13046-017-0644-8 · 2017 · External reference

Inflammatory cytokines mediate the induction of and awakening from metastatic dormancy

10.1016/j.celrep.2025.115388 · 2025 · External reference

The potential role of collagen type VII in breast cancer proliferation

10.1186/s12935-024-03449-4 · 2024 · External reference

Thrombospondins in the tumor microenvironment

10.1016/j.semcdb.2023.05.010 · 2024 · External reference

The dormant cancer cell life cycle

10.1038/s41568-020-0263-0 · 2020 · External reference

Next generation patient derived tumor organoids

10.1016/j.trsl.2022.08.003 · 2022 · External reference

Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study

10.1002/ajh.26039 · 2021 · External reference

Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway

10.1002/iub.2900 · 2024 · External reference

Engineered in vitro models of tumor dormancy and reactivation

10.1186/s13036-018-0120-9 · 2018 · External reference

Therapy-induced senescence: opportunities to improve anticancer therapy

10.1093/jnci/djab064 · 2021 · External reference

YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis

10.1007/s10120-024-01508-3 · 2024 · External reference

Mechanical deformation and death of circulating tumor cells in the bloodstream

10.1007/s10555-024-10198-3 · 2024 · External reference

Biomaterial 3D collagen I gel culture model: A novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment

10.1016/j.biomaterials.2020.120217 · 2020 · External reference

Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells

10.1038/s41568-024-00752-0 · 2024 · External reference

Targeting cancer cell dormancy

10.1016/j.tips.2018.12.004 · 2019 · External reference

Wnt5a induces and maintains prostate cancer cells dormancy in bone

10.1084/jem.20180661 · 2019 · External reference

Gene expression predicts dormant metastatic breast cancer cell phenotype

10.1186/s13058-022-01503-5 · 2022 · External reference

Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis

10.1186/s12943-025-02465-w · 2025 · External reference

Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells

10.1186/s12943-024-01984-2 · 2024 · External reference

Clinical and biological aspects of disseminated tumor cells and dormancy in breast cancer

10.3389/fcell.2022.929893 · 2022 · External reference

The current paradigm and challenges ahead for the dormancy of disseminated tumor cells

10.1038/s43018-020-0088-5 · 2020 · External reference

Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications

10.21037/atm.2020.02.177 · 2020 · External reference

NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells

10.1158/0008-5472.can-21-4145 · 2022 · External reference

A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells

10.1038/s41588-022-01105-z · 2022 · External reference

Cellular dormancy in minimal residual disease following targeted therapy

10.1186/s13058-021-01416-9 · 2021 · External reference

Tumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy

10.1158/0008-5472.can-18-3437 · 2019 · External reference

When dormancy fuels tumour relapse

10.1038/s42003-021-02257-0 · 2021 · External reference

Early recurrence after resection of locally advanced pancreatic cancer following induction therapy: an international multicenter study

10.1097/sla.0000000000005666 · 2023 · External reference

Inflammation control and immunotherapeutic strategies in comprehensive cancer treatment

10.3390/metabo13010123 · 2023 · External reference

Adaptive stress responses during tumor metastasis and dormancy

10.1016/j.trecan.2016.06.004 · 2016 · External reference

Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone

10.1074/jbc.m116.737379 · 2016 · External reference

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

10.3389/fphar.2020.574667 · 2020 · External reference

Syndecan-mediated ligation of ECM proteins triggers proliferative arrest of disseminated tumor cells

10.1158/0008-5472.can-19-1165 · 2019 · External reference

Numerous niches for hematopoietic stem cells remain empty during homeostasis

10.1182/blood-2016-09-740563 · 2017 · External reference

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

10.1172/jci43414 · 2011 · External reference

Targeting cancer stem cells: therapeutic and diagnostic strategies by the virtue of nanoparticles

10.1016/j.jconrel.2022.06.013 · 2022 · External reference

Best approaches and updates for prostate cancer biochemical recurrence

2022 · External reference

5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling

10.1016/j.celrep.2023.112560 · 2023 · External reference

Dormancy of cutaneous melanoma

10.1186/s12935-024-03278-5 · 2024 · External reference

Autophagy, cancer stem cells and drug resistance

10.1002/path.5222 · 2019 · External reference

Bone niches in the regulation of tumour cell dormancy

10.1016/j.jbo.2024.100621 · 2024 · External reference

ERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease

10.1158/1078-0432.ccr-10-2574 · 2011 · External reference

NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes

10.1038/ncomms7170 · 2015 · External reference

Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy

10.1186/s13058-014-0485-8 · 2014 · External reference

Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer

10.1016/j.ajpath.2012.02.027 · 2012 · External reference

PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS/notch/nodal signaling

10.3390/ijms20081916 · 2019 · External reference

PI3K signaling-regulated metabolic reprogramming: From mechanism to application

10.1016/j.bbcan.2023.188952 · 2023 · External reference

Akt-ing up just about everywhere: compartment-specific akt activation and function in receptor tyrosine kinase signaling

10.3389/fcell.2019.00070 · 2019 · External reference

MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells

10.1126/sciadv.abo0876 · 2022 · External reference

Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT

10.1097/hep.0000000000000934 · 2025 · External reference

DIRAS3-derived peptide inhibits autophagy in ovarian cancer cells by binding to beclin1

10.3390/cancers11040557 · 2019 · External reference

DIRAS3 (ARHI) blocks RAS/MAPK signaling by binding directly to RAS and disrupting RAS clusters

10.1016/j.celrep.2019.11.045 · 2019 · External reference

RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells

10.1080/15548627.2018.1427022 · 2018 · External reference

Tumour hypoxia in driving genomic instability and tumour evolution

2025 · External reference

Molecular regulation of cancer cell migration, invasion, and metastasis

2019 · External reference

CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer

10.1038/s41467-021-21045-2 · 2021 · External reference

Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies

10.1002/mog2.70009 · 2025 · External reference

Autophagy inhibition contributes to apoptosis of PLK4 downregulation-induced dormant cells in colorectal cancer

10.7150/ijbs.79949 · 2023 · External reference

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

10.1002/1878-0261.70259 · 2026 · External reference

Immune evasion in head and neck squamous cell carcinoma: roles of cancer-associated fibroblasts, immune checkpoints, and TP53 mutations in the tumor microenvironment

10.3390/cancers17152590 · 2025 · External reference

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

10.1038/srep13574 · 2015 · External reference

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence

2025 · External reference

Meeting the challenge of targeting cancer stem cells

10.3389/fcell.2019.00016 · 2019 · External reference

Crosstalk between oxidative stress-induced apoptotic and autophagic signaling pathways in Zn(II) phthalocyanine photodynamic therapy of melanoma

10.1016/j.freeradbiomed.2020.01.018 · 2020 · External reference

Stem cell quiescence: dynamism, restraint, and cellular idling

10.1016/j.stem.2019.01.001 · 2019 · External reference

Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence

10.1038/s41467-018-04070-6 · 2018 · External reference

A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions

10.1016/j.ijbiomac.2022.09.129 · 2022 · External reference

Defining the role of metastasis-initiating cells in promoting carcinogenesis in ovarian cancer

2023 · External reference

Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation

10.1186/s13046-019-1211-2 · 2019 · External reference

Pre-metastatic niche: formation, characteristics and therapeutic implication

10.1038/s41392-024-01937-7 · 2024 · External reference

DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis

10.1172/jci71812 · 2014 · External reference

Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy

10.1007/s12672-024-01049-2 · 2024 · External reference

Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence

10.1016/j.ccell.2024.08.012 · 2024 · External reference

A cell cycle centric view of tumour dormancy

10.1038/s41416-023-02401-z · 2023 · External reference

Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation

10.1242/jcs.261483 · 2023 · External reference

RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies

10.3389/fcell.2020.00076 · 2020 · External reference

Cancer Stem Cell Markers for Urinary Carcinoma

10.1155/2022/3611677 · 2022 · External reference

The role of tumor microenvironment in regulating tumor cell dormancy

10.1016/j.lfs.2025.124126 · 2026 · External reference

Recent advances in understanding the role of Wnt5a in prostate cancer and bone metastasis

10.1007/s12672-025-02680-3 · 2025 · External reference

AXL signaling in cancer: from molecular insights to targeted therapies

10.1038/s41392-024-02121-7 · 2025 · External reference

Organoid cultures for cancer modeling

10.1016/j.stem.2023.05.012 · 2023 · External reference

Editorial: TGF-β and BMP signaling in cancer

10.3389/fcell.2022.1012326 · 2022 · External reference

Clinical applications of circulating tumor cells in metastasis and therapy

10.1186/s13045-025-01733-y · 2025 · External reference

Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis

10.1038/s41392-024-01789-1 · 2024 · External reference

Roles of the NR2F Family in the Development, Disease, and Cancer of the Lung

10.3390/jdb12030024 · 2024 · External reference

Emerging role of cancer-associated fibroblasts in the premetastatic niche

10.1186/s12943-025-02461-0 · 2025 · External reference

Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma

10.1186/s13046-021-01956-0 · 2021 · External reference

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

10.7150/ijbs.82317 · 2023 · External reference

Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway

10.1158/0008-5472.can-17-1051 · 2018 · External reference

Decoding the dual role of autophagy in cancer through transcriptional and epigenetic regulation

10.1002/1873-3468.70060 · 2025 · External reference

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways

10.1186/s12935-024-03293-6 · 2024 · External reference

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

10.1186/s12967-022-03329-3 · 2022 · External reference

p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia

10.1016/j.molonc.2013.07.011 · 2013 · External reference

Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state

10.1073/pnas.2515009122 · 2025 · External reference

Deciphering the potential role of PGRN in regulating CD8(+) T cell antitumor immunity

10.1038/s41420-024-02001-7 · 2024 · External reference

The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies

2021 · External reference

Hypoxia-driven TNS4 fosters HNSCC tumorigenesis by stabilizing integrin α5β1 complex and triggering FAK-mediated Akt and TGFβ signaling pathways

10.7150/ijbs.86317 · 2024 · External reference

Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis

10.1186/s13045-024-01545-6 · 2024 · External reference

FBX8 promotes metastatic dormancy of colorectal cancer in liver

10.1038/s41419-020-02870-7 · 2020 · External reference

DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7

10.1016/j.cellsig.2023.110893 · 2023 · External reference

Extracellular vesicles in cancer drug resistance: mechanistic insights and therapeutic implications. MedComm –

2024 · External reference